BAMCO Inc’s Minerva Neurosciences NERV Stock Holding History

BAMCO Inc’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-475	Closed	-$23K	–	355
2020 Q1	$23K	Sell	475 -188	-28%	-$11.3K	﹤0.01%	332
2019 Q4	$38K	Buy	+663	New	+$29.2K	﹤0.01%	347

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BAMCO Inc's NERV Position: Q2 2020 in Review

BAMCO Inc sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 475 shares — an estimated $23K sold.

BAMCO Inc first reported a position in NERV in Q4 2019 and held it in 2 quarters. The position peaked at $38K in Q4 2019. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

BAMCO Inc reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
BAMCO Inc sold 475 Minerva Neurosciences shares in Q2 2020, an estimated $23K.
BAMCO Inc first reported a position in Minerva Neurosciences in Q4 2019 and held it in 2 quarters.
BAMCO Inc's Minerva Neurosciences position peaked at $38K in Q4 2019.
80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on BAMCO Inc's 13F filing for Q2 2020, filed 14 Aug 2020.